Injection drug use in North America

Infectious Disease Clinics of North America

Volumn 16, Issue 3, 2002, Pages 535-551

  Schoener, Eugene P ^a   Hopper, John A ^a   Pierre, James D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; PSYCHOTROPIC AGENT;

DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ABUSE; EVIDENCE BASED MEDICINE; HUMAN; INFECTION; INTRAVENOUS DRUG ABUSE; NORTH AMERICA; PREVENTION; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR;

COMMUNICABLE DISEASES; FEMALE; HUMANS; MALE; NORTH AMERICA; PREVALENCE; SEX DISTRIBUTION; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0036739796     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(02)00010-7     Document Type: Review

References (61)

1. Tomas JM, Vlahov D, Anthony JC. Association between intravenous drug use and early misbehavior. Drug Alcohol Depend 1990;25:79-89.
2. Dinwiddie SH. Characteristics of injection drug users derived from a large family study of alcoholism. Compr Psychiatry 1997;38:218-29.
3. Crofts N, Louie R, Rosenthal D, et al. The first hit: circumstances surrounding initiation into injecting. Addiction 1996;91:1187-96.
4. Doherty MC, Garfein RS, Monterroso E, et al. Gender differences in the initiation of injection drug use among young adults. J Urban Health 2000;77:396-414.
5. Hoffmann JP, Su SS, Pach A. Changes in network characteristics and HIV risk behavior among injection drug users. Drug Alcohol Depend 1997;46:41-51.
6. Celentano DD, Munoz A, Cohn S, et al. Dynamics of behavioral risk factors for HIV/ AIDS: a 6-year prospective study of injection drug users. Drug Alcohol Depend 2001; 61:315-22.
7. Battjes RJ, Pickens RW, Haverkos HW, et al. HIV risk factors among injecting drug users in five US cities. AIDS 1994;8:681-7.
8. Booth RE, Watters JK, Chitwood DD. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am J Public Health 1993;83:1144-8.
9. Stein MD, Hanna L, Natarajan R, et al. Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. J Subst Abuse Treat 2000;18:359-63.
10. Hingson RW, Strunin L, Berlin BM, et al. Beliefs about AIDS, use of alcohol and drugs, and unprotected sex among Massachusetts adolescents. Am J Public Health 1990;80: 295-9.
11. Leigh BC, Stall R. Substance use and risky sexual behavior for exposure to HIV. Issues in methodology, interpretation, and prevention. Am Psychol 1993;48:1035-45.
12. Darke S, Pickens RW, Haverkos Ross J, et al. Physical injecting sites among injecting drug users in Sydney, Australia. Drug Alcohol Depend 2001;62:77-82.
13. Thorpe LE, Bailey SL, Huo D, et al. Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999). J Acquir Immune Defic Syndr 2001; 27:71-8.
14. Hunter GM, Stimson GV, Judd A, et al. Measuring injecting risk behaviour in the second decade of harm reduction: a survey of injecting drug users in England. Addiction 2000; 95:1351-61.
15. Koester S, Booth RE, Zhang Y. The prevalence of additional injection-related HIV risk behaviors among injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1996;12:202-7.
16. Kral AH, Lorvick J, Edlin BR. Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J Acquir Immune Defic Syndr 2000;24:162-7.
17. Mandell W, Vlahov D, Latkin C, et al. Correlates of needle sharing among injection drug users. Am J Public Health 1994;84:920-3.
18. Boscarino JA, Avins AL, Woods WJ, et al. Alcohol-related risk factors associated with HIV infection among patients entering alcoholism treatment: implications for prevention. J Stud Alcohol 1995;56:642-53.
19. Woods WJ, Avins AL, Lindan CP, et al. Predictors of HIV-related risk behaviors among heterosexuals in alcoholism treatment. J Stud Alcohol 1996;57:486-93.
20. Chiasson MA, Stoneburner RL, Hildebrandt DS, et al. Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). AIDS 1991;5:1121-6.
21. Seidman SN, Lorvick J, Edlin Sterk-Elifson C, et al. High-risk sexual behavior among drug-using men. Sex Transm Dis 1994;21:173-80.
22. Irwin KL, Edlin BR, Faruque S, et al. Crack cocaine smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission. The Multicenter Crack Cocaine and HIV Infection Study Team. Drug Alcohol Depend 1996;42:85-92.
23. Lipsitz JD, Williams JB, Rabkin JG, et al. Psychopathology in male and female intravenous drug users with and without HIV infection. Am J Psychiatry 1994;151:1662-8.
24. Brooner RK, Schmidt CW, Felch LJ, et al. Antisocial behavior of intravenous drug abusers: implications for diagnosis of antisocial personality disorder, Am J Psychiatry 1992;149:482-7.
25. Dinwiddie SH, Reich T, Cloninger CR. Psychiatric comorbidity and suicidality among intravenous drug users. J Clin Psychiatry 1992;53:364-9.
26. Brooner RK, Bigelow GE, Strain E, et al. Intravenous drug abusers with anti-social personality disorder: increased HIV risk behavior. Drug Alcohol Depend 1990;26: 39-44.
27. King VL, Kidorf MS, Stoller KB, et al. Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment. J Addict Dis 2000; 19:65-83.
28. Hartnoll RL. Opiates: prevalence and demographic factors. Addiction 1994;89:1377-83.
29. Epstein JF, Gfroerer JC. Heroin abuse in the United States. Rockville (MD): Substance Abuse and Mental Health Services Administration; 1997. p. 1-10.
30. Treatment Episode Data Set. Rockville (MD): Office of Applied Studies, Substance Abuse and Mental Health Services Administration; 1998.
31. Summary of findings from the 1999 national household survey on drug abuse. Rockville (MD): Substance Abuse and Mental Health Services Administration (SAMHSA); 2000.
32. Monitoring the future survey. Ann Arbor (MI): National Institute on Drug Abuse, Survey Research Center, Institute for Social Research at the University of Michigan; 2000.
33. Neaigus A, Miller M, Friedman SR, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction 2001;96:847-60.
34. Mathias R. Heroin snorters risk transition to injection drug use and infectious disease. NIDA Notes 1999;14:1-3.
35. Kaye S, Darke S. A comparison of the harms associated with the injection of heroin and amphetamines. Drug Alcohol Depend 2000;58:189-95.
36. Pulse check trends in drug abuse. Washington, DC: Executive Office of the President National Drug Control Policy; 2000.
37. Drug abuse warning network. Rockville, MD: Office of Applied Studies, National Admission to Substance Abuse Treatment Services; 2000.
38. Hopfer CJ, Mikulich SK, Crowley TJ. Heroin use among adolescents in treatment for substance use disorders. J Am Acad Child Adolesc Psychiatry 2000;39:1316-23.
39. Trends in injection drug use among persons entering addiction treatment-New Jersey, 1992-1999. Morb Mortal Wkly Rep (MMWR) 2001;50:378-81.
40. Publication of HIV-prevention bulletin for health-care-providers regarding advice to persons who inject illicit drugs. Morb Mortal Wkly Rep (MMWR) 1997;46:510.
41. Darke SG, Ross JE, Hall WD. Benzodiazepine use among injecting heroin users. Med J Aust 1995;162:645-7.
42. Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Intern Med 1993;119: 1017-28.
43. Stein MD. Injected-drug use: complications and costs in the care of hospitalized HIV-infected patients. J Acquir Immune Defic Syndr 1994;7:469-73.
44. Stein MD, Sobota M. Injection drug users: hospital care and charges. Drug Alcohol Depend 2001;64:117-20.
45. Binswanger IA, Kral AH, Bluthenthal RN, et al. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis 2000;30:579-81.
46. Murphy EL, DeVita D, Liu H, et al. risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis 2001;33:35-40.
47. Chambers HF, Morris DL, Tauber MG, et al. Cocaine use and the risk for endocarditis in intravenous drug users. Ann Intern Med 1987;106:833-6.
48. Zule WA, Vogtsberger KN, Desmond DP. The intravenous injection of illicit drugs and needle sharing: an historical perspective. J Psychoactive Drugs 1997;29:199-204.
49. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1998;47:1-39.
50. Wortley PM, Fleming PL. AIDS in women in the United States. Recent trends. JAMA 1997;278:911-6.
51. Pieper B, Rossi R, Templin T. Pain associated with venous ulcers in injecting drug users. Ostomy Wound Management 1998;44:54-67.
52. McLellan AT, Arndt IO, Metzger DS, et al. The effects of psychosocial services in substance abuse treatment. JAMA 1993;269:1953-9.
53. Burris S, Lurie P, Abrahamson D, et al. Physician prescribing of sterile injection equipment to prevent HIV infection: time for action. Ann Intern Med 2000;133:218-26.
54. Vlahov D, Sullivan M, Astemborski J, et al. Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Rep 1992;107:595-8.
55. Siegal HA, Carlson RG, Falck R, et al. Injection drug users' needle-cleaning practices, Am J Public Health 1994;84:1523-4.
56. Tetanus among injecting-drug users-California, 1997. Morb Mortal Wkly Rep (MMWR) 1998;47:149-51.
57. Boschini A, Smacchia C, Di Fine M, et al. Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies, and clinical aspects. Clin Infect Dis 1996;23:107-13.
58. Selwyn PA, Feingold AR, Hartel D, et al. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS 1988;2:267-72.
59. Stancliff S, Salomon N, Perlman DC, et al. Provision of influenza and pneumococcal vaccines to injection drug users at a syringe exchange. J Subst Abuse Treat 2000;18:263-5.
60. Hepatitis B vaccination for injection drug users-Pierce County, Washington, 2000. Morb Mortal Wkly Rep (MMWR) 2001;50:388-90, 399.
61. Akriviadis EA, Redeker AG. Fulminant hepatitis A in intravenous drug users with chronic liver disease. Ann Intern Med 1989;110:838-9.